BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

Becton Dickinson launched a new syringe specifically for use with Eli Lilly’s concentrated insulin, which is prescribed for diabetics who need to inject higher doses of insulin daily. Previously, ...

BD has issued a recall for the BD Insulin Syringes with the BD Ultra-Fine needle ½mL 12.7mm 30G, Cat (Ref) 328466 with Lot# 6291768. BD has issued a recall for the BD Insulin Syringes with the BD ...

The BD U-500 Insulin Syringe is specifically designed to administer the Humulin R U-500 insulin among patients properly. The Humulin R U-500 insulin is prescribed to patients who need a higher dose of ...

On the heels of the Health Service Medical Supplies (Costs) Act of 2017, effective this month, BD (Becton, Dickinson and Company) announced the BD Viva™ brand of insulin pen needles are now the most ...

After the U.S. Food and Drug Administration announced an investigation into reports of leaks, breakages and other quality issues with China-made plastic syringes, New Jersey-based medical technology ...

Insulin syringes were the only commonly used way of delivering insulin for much of the 20th century. Towards the end of the 1990s, insulin pens became more commonly used. Whilst less popular these ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has increased its manufacturing capacity for critical ...